MusclePharm Corporation
MSLPQ
$0.00
$0.000.00%
| 03/31/2022 | 12/31/2021 | 09/30/2021 | 06/30/2021 | 03/31/2021 | |
|---|---|---|---|---|---|
| Net Income | -6.30M | -6.78M | -3.93M | -2.25M | 94.00K |
| Total Depreciation and Amortization | 36.00K | 82.00K | 83.00K | 82.00K | 84.00K |
| Total Amortization of Deferred Charges | 2.62M | 2.30M | -- | -- | -- |
| Total Other Non-Cash Items | 650.00K | -599.00K | 378.00K | 568.00K | 75.00K |
| Change in Net Operating Assets | -582.00K | -579.00K | 1.91M | 604.00K | -155.00K |
| Cash from Operations | -3.58M | -5.58M | -1.57M | -997.00K | 98.00K |
| Capital Expenditure | -- | 1.00K | 0.00 | 1.00K | -4.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 1.00K | 0.00 | 1.00K | -4.00K |
| Total Debt Issued | 13.66M | 18.21M | 12.04M | 16.11M | 12.48M |
| Total Debt Repaid | -10.77M | -10.95M | -11.11M | -14.69M | -13.99M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -848.00K | -- | -- | -- |
| Cash from Financing | 2.89M | 6.41M | 935.00K | 1.42M | -1.51M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -689.00K | 839.00K | -632.00K | 424.00K | -1.41M |
